Visit our Covid-19 Guidance Hub Click here
I am an independent business consultant at HW Fisher, supporting the forensic accounting team on strategic priorities and new business opportunities with a particular focus on the pharma industry.
I have over 20 years’ experience in the pharma industry with AstraZeneca as well as a further 10 years in the chemicals industry.
A finance professional, I have extensive leadership experience and exposure at board and C-Suite level and have operated across AstraZeneca’s commercial and research & development organisations.
I have a wealth of international experience and am accustomed to driving business and partnership developments in high-pressure environments across the US, Europe and Asia.
A particular highlight was a spell as CFO and board member for AstraZeneca’s affiliate in Italy at a time of multiple product launches and organisational re-alignment.
In my most recent role at AstraZeneca I conceived, developed and led a programme to identify cost saving opportunities across the organisation using a data-led, hypothesis driven approach, utilising innovative analytical techniques to uncover new opportunities. A material level of savings were, (and continue to be) delivered and incorporated a commercial assurance programme including contract and royalty agreement audits.